Healthcare Momentum Supports FTSE 100 as Manufacturing PMI Declines

Highlights

• Healthcare stocks including AZN, HIK and GSK supported the ftse 100 despite weaker UK manufacturing PMI readings

• GRG advanced after reporting improved performance, while TATE declined following subdued earnings expectations

• Broader European indices such as the DAX and CAC 40 also recorded gains led by healthcare companies including RO and MRCG

Healthcare strength from AZN, HIK and GSK lifted the ftse 100, while GRG gained on retail performance and TATE declined on softer demand outlook.

Healthcare remained the defining feature of the trading day, lifting the ftse 100 even as economic indicators pointed to pressure in domestic manufacturing. AstraZeneca PLC (LSE:AZN), Hikma Pharmaceuticals PLC (LSE:HIK) and GSK PLC (LSE:GSK) delivered strength in the healthcare space. Their performance was supported by positive developments in the United States, where Pfizer Inc (PFE) confirmed an agreement on prescription drug pricing. The ripple effect spread across Europe, with Roche Holding AG (RO) and Merck KGaA (MRCG) recording notable upward moves. The resilience of healthcare within the broader ftse framework helped cushion the impact of weakening macroeconomic data in the United Kingdom.

Why Did Healthcare Companies Rise in the FTSE 100?

Healthcare has traditionally been seen as an anchor during periods of uncertainty. The clarity provided by the Pfizer agreement on drug pricing reinforced stability across pharmaceutical shares. AZN and HIK displayed strong upward moves, while GSK also gained ground, underscoring the collective weight of the sector within the ftse 350. European peers strengthened as well, with Ambu A/S (AMBUb) and Sartorius AG (SATG) moving higher alongside the larger companies MRCG and RO.

Broader European Market Movements

The positive tone was not confined to London. The DAX index in Germany and the CAC 40 in France gained momentum, supported by healthcare-led strength. MRCG and RO played central roles in pushing the healthcare category higher. This regional rally was in line with the uplift observed within the FTSE AIM 100 Index, emphasising the sector’s ability to underpin wider markets during challenging economic cycles.

Performance of Greggs PLC (GRG) in the Retail Segment

Outside of healthcare, Greggs PLC (LSE:GRG) delivered a positive update on performance. The bakery chain reported growth in total as well as improvements in like-for-like metrics for company-managed shops. The increase reflected resilience in consumer-facing retail activity. GRG’s showing provided support within the ftse small cap, highlighting the capacity of retail to maintain momentum despite broader cost-of-living challenges in the UK market.

Tate & Lyle PLC (TATE) Decline Amid Softer Outlook

In contrast, Tate & Lyle PLC (LSE:TATE) warned that both revenue and EBITDA would decline in the financial year ending March. The food ingredients maker cited weaker demand conditions in the Americas and additional difficulties in European markets. The statement resulted in a pronounced fall in its share price. This weakness dampened overall sentiment within the sector, despite healthcare’s strength on the day. Companies in this category remain relevant within the FTSE Dividend Stocks landscape, but subdued forecasts weighed heavily on near-term trading reactions.

UK Manufacturing PMI Points to Weakness

While healthcare offset declines, the broader economic picture told a different story. The S&P Global UK Manufacturing Purchasing Managers’ Index fell further, extending its run below the neutral reading. This marked a full year of contraction for manufacturing activity in Britain. Factories reported reduced orders and continued concerns over input costs, reflecting pressure in both domestic and overseas demand. The survey highlighted the extent to which manufacturing continues to lag other sectors of the economy, posing challenges for the outlook of the ftse 250.

How Did the Bank of England Respond?

Catherine Mann, a policymaker at the Bank of England, commented that monetary policy remains relatively loose in comparison to inflation and economic activity levels. Mann explained that leaving interest rates unchanged was appropriate for the current circumstances but noted the importance of keeping inflation expectations anchored. Any drift in expectations could extend the persistence of inflationary pressures. These remarks provided additional context for the performance of sterling against the dollar, which strengthened modestly during the session. The policy backdrop remains relevant for broader FTSE AIM UK 50 INDEX constituents as monetary conditions shape financing costs across listed companies.

UK Housing Market Displays Stability

Property values in the UK moved higher during September, following a small decline in August. Data from Nationwide Building Society suggested resilience in the housing market despite pressures from higher borrowing costs. Residential activity remained supported by stable employment levels and seasonal demand. The data offered a counterbalance to the weaker manufacturing report, signalling a mixed picture across the UK economy. For companies with retail exposure such as GRG, housing stability can feed into consumer sentiment and spending habits.

How Did Pfizer (PFE) Shape Market Sentiment?

Pfizer Inc (LSE:PFE) played a decisive role in shaping global healthcare sentiment. The company announced that it reached an understanding with the United States administration to reduce prescription drug costs under the Medicaid programme in return for tariff relief. This agreement helped ease policy-related uncertainty in the pharmaceutical industry. The ripple effects were felt not only across American healthcare companies but also in Europe and the UK. As a result, stocks such as AZN, HIK, and GSK in the ftse 100 responded positively.

European Healthcare Giants Add Momentum

Healthcare stocks in Europe rallied in parallel with those listed in London. MRCG surged in Frankfurt, while RO advanced in Zurich. These companies, along with others in the healthcare segment, benefited from easing policy uncertainty around pricing. Ambu A/S (AMBUb) and Sartorius AG (SATG) also joined the upward movement. This sector-wide strength reaffirmed healthcare’s status as a stabilising factor for indices including the DAX and CAC 40, alongside UK-based benchmarks.

Impact on Currency Movements

Sterling recorded modest appreciation against the US dollar during the trading session. The move came in response to policy remarks from the Bank of England and ongoing expectations for inflation management. Currency dynamics often influence exporters within the ftse 100, particularly companies with significant overseas revenue streams such as AZN and GSK. Gains in sterling can affect margins for such firms, but the positive healthcare performance counterbalanced this factor on the day.

Retail and Consumer Dynamics

The retail segment drew attention through GRG’s performance. The bakery chain highlighted steady growth in its year-to-date results. This resilience contrasts with ongoing challenges faced by many consumer-facing businesses amid inflationary pressure. GRG’s improvement suggested that affordable and convenience-driven food offerings continue to resonate with the public, even as discretionary categories experience pressure. This aligns with broader consumer dynamics influencing the ftse small cap.

Food Ingredients Sector Challenges

TATE’s update reinforced the challenges currently faced by companies operating within food production and ingredient supply chains. Weak demand in the Americas and slower European trends point to an uncertain environment. The company highlighted expectations of revenue and EBITDA declines, with currency factors further complicating its outlook. The statement served as a reminder of the divergence between healthcare-led gains and pressures in other sectors on the same trading day.